Elsevier

Journal of Organometallic Chemistry

Volume 776, 15 January 2015, Pages 35-42
Journal of Organometallic Chemistry

An unexpected pentacarbonyl chromium complexation of a cyano group of the ABC core of cephalotaxine

https://doi.org/10.1016/j.jorganchem.2014.10.040Get rights and content

Highlights

  • Preparation of chromium carbonyl complexes with benzodioxole-containing ligands.

  • Chromium complexes were characterized using X-ray diffraction.

  • Safrole chromium tricarbonyl complex has a staggered conformation.

  • Complexation of a cyano-pyrrolobenzazepine led to a Ctriple bondN → Cr coordination.

  • Irrespective of the transfer agent, its pentacarbonyl chromium complex is formed.

Abstract

A new penta-carbonyl chromium(0) complex of the type [Cr(CO)5(L)] (L = tetracyclic pyrrolobenzazepine unit 3) was surprisingly obtained by reacting [Cr(CO)3(naphthalene)] or [Cr(CO)3(tmtach)] with the tetracyclic pyrrolobenzazepine unit 3 in octane-ether/THF-solvent mixtures or acetone under ambient temperature or reflux. The new complex 13 has been characterized by spectral analysis including IR, 1H and 13C NMR data. For comparison purposes, the safrole-tricarbonyl chromium(0) complex 12 was prepared and characterized. X-ray diffraction analyses of both complexes were determined. Based on the above data, an octahedral structure has been assigned to the new complex 13.

Graphical abstract

Contrary to safrole which reacts with chromium carbonyl to give the expected arene tricarbonyl chromium species, its derivative bearing an enamino-nitrile function leads, in the presence of transfer agents, [Cr(CO)3(naphthalene)] or [Cr(CO)3(tmtach)], to a pentacarbonyl chromium complex at the electron rich nitrile nitrogen atom.

  1. Download : Download full-size image

Introduction

The biological activity of a number of ester derivatives of cephalotaxine (1) is remarkable, as illustrated by homoharringtonine (HHT) (2) (Omacetaxine mepesuccinate® (Fig. 1) [1]. HHT (2) has an IC50 of 0.017 μg/mL against the cell line P-388 [2] and demonstrated clinical activity in chronic myeloid leukemia (CML) and acute myeloid leukemia (AML) through binding to the ribosome thus inhibiting protein synthesis [3] and promoting cell death by apoptosis [4]. The activity of HHT (2) has been demonstrated by more than 50 clinical studies, primarily sponsored by the National Cancer Institute (NCI) in the United States, and in China. HHT (2) is used for the treatment of leukemia in China and has received its approval in Europe as an orphan drug and was approved by the FDA in October 2012 as a treatment for acute myeloid leukemia for patients who are resistant to two tyrosine kinase inhibitors [5]. Thanks to this clinical importance, and due to its unique pentacyclic structure, the alkaloid core cephalotaxine (1) became an attractive target for the chemists. Since the publication of its first synthesis by Weinreb and Semmelhack in 1972 [6], 24 racemic syntheses, 19 enantioselective syntheses of (−)-cephalotaxine (natural configuration) and one of the (+)-enantiomer have been published [7].

In our attempt to complete the total synthesis of ()-cephalotaxine 1, the tetracyclic pyrrolobenzazepine unit 3, which could be regarded as a potential precursor of cephalotaxine 1 missing only two carbon atoms (C1–C2) of elaboration of the D ring, was prepared with a 16.2% overall yield in a concise eight-step sequence from inexpensive safrole [8]. However, nucleophilic addition to this compound, a prerequisite to the formation of the D ring of 1, was not possible [9]. This unexpected reactivity was explained by the almost null partial charges at C3 and C5 positions, which were accurately determined experimentally by high-resolution X-ray diffraction studies at 100 K. We have therefore envisaged the substitution of the A ring by an electron withdrawing chromium tricarbonyl substituent to reverse this unusual electronic distribution (Fig. 2), hoping that this would allow the addition of a nucleophile bringing the two missing carbon atoms needed to complete the D cycle of the cephalotaxine 1 skeleton.

Indeed, the neutral [(η6-arene)Cr(CO)3] motif has been taking a growing place in organometallic chemistry as well as in organic synthesis [10]. The electrophilicity of an arene is dramatically enhanced by coordination to a tricarbonyl metal entity (M(CO)3; M = Cr, Mn+), allowing several transformations which cannot be carried out on the metal-free arene ring. Thus there has been widespread interest in the chemistry of arene-metal complexes and, among them, (η6-ArH)Cr(CO)3 complexes have been extensively studied [11], [12], [13], [14]. These complexes are used in many synthetic applications including diastereoselective and enantioselective synthesis, chiral ligand design [15], [16] and total synthesis [17]. In particular, it has been shown that nucleophilic attack of Cr(CO)3 substituted arenes bearing a conjugated double bond led to a stabilized benzyl anion through addition of the nucleophile at the β position [18], [19], [20], [21].

We report herein on the unexpected results dealing with the formation of a pentacarbonyl chromium carbonyl species starting from tetracyclic pyrrolobenzazepine unit 3.

Section snippets

Preparation of the organic ligand 3

Compound 3 was synthesized from safrole 5 in a concise eight-step sequence with an overall yield of 16.2% (Scheme 1).

The synthesis of compound 6 was accomplished by reductive ozonolysis of the vinylic side chain terminus of safrole 5 [22]. Nucleophilic substitution of the resulting alcohol function by bromine yielded 7 in 72.8% yield from safrole (2 steps). The C ring of cephalotaxine 1 was introduced by nucleophilic substitution of the bromide atom of 7 by the sodium salt of succinimide

Conclusion

In order to modify the reactivity of a pyrrolobenzazepine unit toward nucleophilic attack, we envisaged its transformation into an arene chromium tricarbonyl complex. Unexpectedly, the reaction conditions used led to a chromium pentacarbonyl complex where the metal was linked to the nitrogen atom of the organic framework. The study of the nucleophilic attack of this complex is now under progress and will be reported in due course.

General

TLC analyses were carried out on aluminum sheets precoated with silica gel (60 F254) and visualized with UV light, staining at 100 °C was performed using Kägi–Misher reagent. Purification by column chromatography was performed using 70–230 mesh silica gel (Merck). NMR spectra were recorded with a Bruker Advance DRX 500 FT spectrometer [400 MHz (1H) and 100 MHz (13C)] or a Bruker AH 300 FT spectrometer [300 MHz (1H) and 75 MHz (13C)]. Chemical shifts are expressed in ppm downfield from TMS. Data

Acknowledgments

The authors thank P Kündig (University of Geneva, Switzerland) for a gift of naphthalene chromium complex, Dr Françoise Rose-Munch (University P & M Curie, Paris, France) and Pr Khalil Asali (Jordan University of Science & Technology, Irbid, Jordan) for stimulating scientific discussions, Dr Joseph Ferrara (Rigaku Americas Corporation) for great help in twin deconvolution regarding data collected from the crystallized compound 13, Estelle Morvan (Faculty of Pharmacy, Châtenay-Malabry, France)

References (41)

  • I. Takano et al.

    Bioorg. Med. Chem. Lett.

    (1996)
  • G. Gürel et al.

    J. Mol. Biol.

    (2009)
  • D. Schinzer et al.

    Synlett

    (1997)
  • C.A.L. Mahaffy et al.

    Inorg. Synth.

    (1990)
  • L. Knoll et al.

    Chem. Ber.

    (1979)
  • N.L. Armanasco et al.

    J. Chem. Soc. Dalton Trans.

    (1997)
  • Nonius

    COLLECT

    (1999)
  • O.V. Dolomanov et al.

    J. Appl. Crystallogr.

    (2009)
  • W.H. Bunnelle

    Chem. Rev.

    (1991)
  • Y. Jin et al.

    Mol. Cancer Ther.

    (2010)
  • R. Tang et al.

    Mol. Cancer Ther.

    (2006)
  • H.M. Kantarjian et al.

    J. Clin. Oncol.

    (2000)
  • J. Auerbach et al.

    J. Am. Chem. Soc.

    (1972)
    M.F. Semmelhack et al.

    J. Am. Chem. Soc.

    (1972)
    M.F. Semmelhack et al.

    Tetrahedron Lett.

    (1973)
  • H. Abdelkafi et al.

    Nat. Prod. Rep.

    (2012)
    M. Pizzonero et al.

    Heterocycles

    (2005)
    B.M. Trost et al.

    Org. Lett.

    (2012)
    Q.-W. Zhang et al.

    Chem. Asian J.

    (2012)
    M.G. Gonçalves-Martin et al.

    Helv. Chim. Acta

    (2012)
    P. Xing et al.

    Synthesis

    (2013)
    Z.-W. Zhang et al.

    J. Org. Chem.

    (2013)
    K.-J. Xiao et al.

    Chem. Eur. J.

    (2013)
  • E.R. de Oliveira et al.

    Tetrahedron Lett.

    (1997)
  • M. Pizzonero et al.

    J. Org. Chem.

    (2004)
  • M. Uemura
  • F. Rose-Munch et al.

    Curr. Org. Chem.

    (1999)
  • M. Rosillo et al.

    Chem. Soc. Rev.

    (2007)
  • Cited by (4)

    • Group VI Metal Complexes of Carbon Monoxide and Isocyanides

      2022, Comprehensive Organometallic Chemistry IV: Volume 1-15
    • Experimental and mathematical modeling of Cr(VI) removal using nano-magnetic Fe<inf>3</inf>O<inf>4</inf>-coated perlite from the liquid phase

      2020, Chinese Journal of Chemical Engineering
      Citation Excerpt :

      Hence, Cr(VI) should be removed from the environmentally relevant water. Several techniques are employed for the removal and recovery of chromium ions including; membrane processes [6], chemical precipitation [7], complexation [8], solvent extraction [9], ion exchange [10], and adsorption [11]. The adsorption technique remains among the greatest utilized techniques and easy to implement; it has further flexibility in setup and operation and produces high-quality treated effluent [12].

    • Cephalotaxus Alkaloids

      2017, Alkaloids: Chemistry and Biology
      Citation Excerpt :

      This compound was converted into ketal and then submitted to hydrogenolysis to deliver the target spiroketal amide (−)-304. By relying on Royer132 and Kuehne's procedures,94 using tosylate 305 obtained in two steps and 76.5% OY from safrole (317)117,118 via 2-arylethanol 211, the synthesis of CET (−)-(1) could be achieved in expected ee ≥ 95%, 20 steps from β-ketoester 105 and calculated 5.1% OY (Scheme 30). In 1999, Ikeda et al. developed an asymmetric version137 of their racemic synthesis.130,138

    • 6.05 - Group VI Metal Complexes of Carbon Monoxide and Isocyanides

      2022, Comprehensive Organometallic Chemistry IV: Volume 1-15
    View full text